Christina Correnti, MD
Dermatology · Dover, NHNPI 1225457880
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 284 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 29.4% of the total.
Across 284 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$692
- Novartis$642
- E.r. Squibb & Sons, L.L.C.$510
- Lilly USA, LLC$425
- Incyte Corporation$382
- plus $1K from 20 others
What the payments were for
- Food & beverage$5,33397%
- Education$1643%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 96 | $1,614 |
| Johnson & Johnson | 31 | $692 |
| Novartis | 37 | $642 |
| E.r. Squibb & Sons, L.L.C. | 25 | $510 |
| Lilly USA, LLC | 19 | $425 |
| Incyte Corporation | 18 | $382 |
| UCB, Inc. | 14 | $209 |
| LEO Pharma Inc. | 7 | $190 |
| Pfizer | 8 | $159 |
| Amgen | 5 | $119 |
| Mayne Pharma Commercial LLC | 4 | $86 |
| Sun Pharmaceutical Industries Inc. | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Verrica Pharmaceuticals Inc. | 2 | $49 |
| Sanofi | 2 | $36 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $34 |
| Dermira, Inc. | 1 | $33 |
| AstraZeneca | 1 | $32 |
| Boehringer Ingelheim | 1 | $28 |
| Fresenius Kabi USA, LLC | 1 | $28 |
| Biofrontera Inc. | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| Organon | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Almirall LLC | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $14 |
How this compares
$5,497 in reported general payments places this provider in the 65th percentile of 75 dermatology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 12 | $462 |
| Cephalexin | 51 | $383 |
| Minocycline Hcl | 12 | $241 |
| Doxycycline Hyclate | 30 | $191 |
| Doxycycline Monohydrate | 12 | $106 |
| Mupirocin | 15 | $100 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Dover
- Robert MurgiaDover$6K
- Molly PlovanichDover$862
- Abel JarellPortsmouth$2.3M
- Robert PosnickNashua$951K
- David PosnickNashua$203K
- Yulianna RussakLebanon$170K
- Peter JenkinManchester$117K
- Neera NathanLondonderry$83K
- Michael LichterNashua$53K
- Michael ChapmanLebanon$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.